Microbial Transformation and Biological Activities of the Prenylated Aromatic Compounds from Broussonetia kazinoki

has been used as a traditional medicine for the treatment of burns and acne, and its extracts have been found to show tyrosinase inhibitory and anticancer activities. In this study, the tyrosinase inhibitory and cytotoxic activities of were explored, leading to the isolation of kazinol C ( ), kazino...

Full description

Saved in:
Bibliographic Details
Published in:Molecules (Basel, Switzerland) Vol. 27; no. 6; p. 1879
Main Authors: Choi, EunA, Han, Fubo, Park, Jisu, Lee, Ik-Soo
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 14-03-2022
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:has been used as a traditional medicine for the treatment of burns and acne, and its extracts have been found to show tyrosinase inhibitory and anticancer activities. In this study, the tyrosinase inhibitory and cytotoxic activities of were explored, leading to the isolation of kazinol C ( ), kazinol E ( ), kazinol F ( ), broussonol N ( ), and kazinol X ( ), of which the compounds and have not been previously reported. Microbial transformation has been recognized as an efficient tool to generate more active metabolites. Microbial transformation of the major compounds and was conducted with , where four glucosylated metabolites ( - ) were produced from , while one hydroxylated ( ) and one glucosylated ( ) metabolites were obtained from . Structures of the isolated metabolites were determined by extensive spectroscopic analyses. All compounds were evaluated for their tyrosinase inhibitory and cytotoxic activities. Compound and its metabolites, kazinol Y ( ) and kazinol F-4″- -β-d-glucopyranoside ( ), exhibited the most potent tyrosinase inhibitory activities with the IC values ranging from 0.71 to 3.36 µM. Meanwhile, none of the metabolites, except for kazinol C-2',3″-di- -β-d-glucopyranoside ( ), showed moderate cytotoxic activities (IC 17.80 to 24.22 µM) against A375P, B16F10 and B16F1 cell lines.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current address: Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup-si 56212, Korea.
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules27061879